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Aortic stenosis has an increasing prevalence in the context of aging population. In these patients non-invasive imaging
allows not only the grading of valve stenosis severity, but also the assessment of left ventricular function. These two goals
play a key role in clinical decision-making. Although left ventricular ejection fraction is currently the only left ventricular
function parameter that guides intervention, current imaging techniques are able to detect early changes in LV structure
and function even in asymptomatic patients with significant aortic stenosis and preserved ejection fraction. Moreover,
new imaging parameters emerged as predictors of disease progression in patients with aortic stenosis. Although proper
standardization and confirmatory data from large prospective studies are needed, these novel parameters have the
potential of becoming useful tools in guiding intervention in asymptomatic patients with aortic stenosis and stratify
risk in symptomatic patients undergoing aortic valve replacement.
This review focuses on the mechanisms of transition from compensatory left ventricular hypertrophy to left ventricular
dysfunction and heart failure in aortic stenosis and the role of non-invasive imaging assessment of the left ventricular
geometry and function in these patients.
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Aortic stenosis (AS) is the third most common cardio-
vascular disease in Western countries and the main indi-
cation for valve replacement in adult patients [1]. The
assessment of AS severity, symptomatic status and left
ventricular (LV) systolic function have the key role in
patients' management algorithm [2,3].
Left ventricular ejection fraction (LVEF) is currently
the only LV function parameter that guides intervention
in asymptomatic patients with severe AS [2]. Even in pa-
tients with AS and preserved LVEF current imaging
techniques allow the detection of subtle LV structural
and functional changes that might alter the long-term
prognosis [4,5]. In addition, some of the patients with
normal LVEF have reduced transvalvular flow rate that
entails significant challenges with regards to evaluation
and clinical decision-making [6]. This review focuses on* Correspondence: bogdan.a.popescu@gmail.com
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unless otherwise stated.the mechanisms of progression from compensatory LV
hypertrophy (LVH) to LV dysfunction and heart failure
(HF) in AS and on specific issues regarding the noninva-
sive imaging assessment of LV structure and function in
these patients.Left ventricular hypertrophy as a compensatory
mechanism in aortic stenosis
Concentric hypertrophy is the main compensatory mech-
anism for pressure overload [7] in patients with significant
AS. The increase of contractile elements leads to in-
creased contractile force and reduces systolic wall stress.
Thus, despite very high intraventricular systolic pressure,
cardiac output and filling pressures may remain within
normal limits.
Although valvular obstruction is the most important
stimulus for LVH in patients with AS, the LV response
depends not only on the severity of AS, but also on a
multitude of individual factors. Age, gender, genetic vari-
ation in the renin–angiotensin system, co-existing coron-
ary artery disease, hypertension, or significant associatedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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response of the LV to increased valvular load [8-12].
In patients with concomitant systemic hypertension,
an increase in blood pressure superimposed on an in-
creased valvular resistance leads to a significant increase
in LV systolic wall stress. The contribution of vascular
load is essential to be recognized in all patients with AS,
as it further increases LV global afterload, which is asso-
ciated with decreased stroke volume, impaired myocar-
dial function and reduced survival [13].
Pathophysiology of left ventricular dysfunction in aortic
stenosis
If the valvular obstacle is not removed, the adaptive
mechanisms to pressure overload are exceeded, either
because the limit of sarcomere extension is reached or
because marked LVH with increased diastolic stiffness
prevents adequate LV filling [14]. The LV becomes un-
able to maintain a normal stroke volume in the setting
of limited preload reserve, a condition known as "after-
load mismatch". Consequently, systolic wall stress be-
comes markedly elevated, and LVEF decreases. Left
ventricular dilation might be present in this late phase,
with eccentric LV remodelling or hypertrophy. In the ab-
sence of significant coronary lesions, reduced LVEF in
AS occurs only in end-stage disease, and is usually pre-
ceded by symptom occurrence. Nevertheless, cardiac
events may occur in patients with AS before the decline
of LVEF. The afterload mismatch state definition implies
that myocardial contractility is not depressed, and the
relief of valvular obstruction will allow an efficient re-
covery of the LV in terms of size and function [14]. An
improvement of LV systolic function is observed in most
of these patients after successful AVR [15]. However,
diastolic dysfunction and an abnormal response to exer-
cise may persist for several years after AVR, even in pa-
tients with normal LVEF [16].
A large number of experimental and clinical studies
addressed the transition from the "compensated state" of
LVH to overt HF in AS and proposed a series of poten-
tial underlying mechanisms. Interstitial myocardial fibro-
sis, myocyte degeneration, and apoptosis are early
structural changes in patients with severe AS, their ex-
tent being related to increasing LV filling pressures and
decreased LVEF [17].
Impaired coronary flow reserve and inadequate suben-
docardial blood flow are found in patients with AS even
in the absence of significant coronary artery disease [18].
These are related to the severity of AS, haemodynamic
load on the LV, and reduced diastolic perfusion time, ra-
ther than to the increase in LV mass [18] and may repre-
sent the substrate for LV longitudinal dysfunction. This is
an early finding in patients with significant AS even in the
presence of a normal LVEF [5]. Compensatory changes inLV geometry with increased relative wall thickness (RWT)
and preserved radial and circumferential function, mainly
determined by mid-wall myocardial fibers, may explain
the preservation of LVEF in these patients [5].
Diastolic dysfunction has an important role in the
pathogenesis of symptoms and the progression to HF in
patients with AS [19]. It appears early in the disease
process as the result of LVH and interstitial fibrosis [17]
with subsequent impaired relaxation and increased LV
chamber stiffness.
Noninvasive assessment of left ventricular function – specific
issues in aortic stenosis
An accurate assessment of LV remodelling and function is
warranted in all patients with significant AS. The identifi-
cation of early signs of impaired myocardial contractility is
particularly important in asymptomatic patients with se-
vere AS. A series of new noninvasive imaging derived pa-
rameters of LV function emerged as predictors of disease
progression in AS.
Echocardiography - conventional measurements and additional
parameters of LV function
Echocardiography remains the investigation of choice
both for the assessment of AS severity and LV function.
Linear LV dimensions should be measured in all patients
based on existing recommendations [20] for further esti-
mation of LV mass and RWT, in order to classify the type
of LV remodelling (Figure 1). The currently accepted con-
cept of LVH is based on data obtained using conventional
echocardiography for the assessment of LV mass.
Three-dimensional echocardiography overcomes the
inherent geometrical assumptions from 2D echocardiog-
raphy and its accuracy in measuring LV volumes and
mass was already demonstrated against cardiac magnetic
resonance imaging (CMR) [21], but lack of specific cut-
off values hampers its use in clinical practice.
Conventional echocardiography allows the estimation
of LV systolic function by measuring LV endocardial and
midwall fractional shortening, LVEF, mitral annular plane
systolic excursion (MAPSE), LV stroke volume and myo-
cardial performance index. Both LV endocardial shortening
fraction and LVEF are derived by measuring endocardial
displacement, and both overestimate systolic function in
the presence of concentric LVH. Mitral annular plane sys-
tolic excursion reflects global LV longitudinal systolic func-
tion and is a more sensitive marker of systolic dysfunction
compared to LVEF. It declines with increasing AS severity
independent of LVH, implying a direct relation with the in-
creased haemodynamic load [22]. Decreased MAPSE is re-
lated to increased subendocardial fibrosis and a cut-off
value of 9 mm had an excellent accuracy to distinguish be-
tween moderate and severe AS [23]. This might be particu-
larly useful in the challenging clinical scenario of low-
Figure 1 Classification of LV geometry type based on relative wall thickness (RWT) and left ventricular mass index (LVMi). Each type of abnormal
LV geometry is illustrated by M-mode images obtained in patients with severe AS.
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entiate patients with truly severe AS from those with mod-
erate AS.
Accurate calculation of LV stroke volume (using LV
outflow tract time-velocity integral and diameter) must
be included in the echocardiographic evaluation of patients
with AS, especially in patients with severe AS (based on
aortic valve area calculation), preserved LVEF (>50%) and a
low transvalvular gradient (mean gradient < 40 mmHg). A
cut-off value of < 35 ml/m2 is an essential criterion for the
definition of paradoxical low-flow AS [3,13]. These patients
have typical echocardiographic aspects including a small
LV cavity size, impaired LV filling, reduced arterial compli-
ance and elevated valvulo-arterial impedance reflecting a
higher LV global load [13]. Recently published data revealed
that many of these patients have a severe AS when using
aortic valve weight as a reference method [24].
Although LVEF below 50% is the only parameter of LV
function that guides intervention in patients with severe
AS [2], it is not a good measure of myocardial contractil-
ity. Moreover, LVEF is mainly determined by radial func-
tion, which can be normal for a long time, even in the
presence of subendocardial fibrosis [23].
A separate analysis of the various components of LV
deformation by current echocardiographic techniques al-
lows a better understanding of progression to HF in pa-
tients with AS and an early detection of asymptomaticpatients who are most likely to benefit from more ag-
gressive intervention.
A series of clinical studies based on tissue Doppler im-
aging (TDI) assessed subtle changes in LV function in
patients with significant AS and preserved LVEF. Peak
systolic annular velocities (S') were significantly reduced
in non-ischemic patients with moderate and severe AS,
in the presence of normal LVEF and cardiac index
[4,25]. Longitudinal systolic strain and strain rate param-
eters were also significantly decreased in these patients,
their decline being related to the severity of AS [26]. A
rapid improvement of these parameters was demonstrated
after aortic valve replacement (AVR), before any signifi-
cant changes in LV mass and LVEF, suggesting that they
partially depend on the presence of LV afterload [26,27].
Two-dimensional speckle-tracking echocardiography
(2D-STE) allows a multidirectional angle-independent
evaluation of myocardial deformation providing a com-
prehensive assessment of LV function [28]. The results
from clinical studies using 2D-STE in patients with se-
vere AS and preserved LVEF confirmed the significant
decrease in LV longitudinal strain [5,29-31] (especially in
the basal segments) and showed the impact of reduced
longitudinal deformation on exercise capacity and prog-
nosis in asymptomatic patients [5]. More cardiac events
were observed during follow-up in patients with lower
values of longitudinal strain in the LV basal segments
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below −18% predicted an abnormal exercise response
with a sensitivity of 68% and a specificity of 77% [5].
Average longitudinal strain depends not only on AS se-
verity but also on the type of LV remodelling, with lower
values in patients with higher LV mass and RWT [29].
A gradual impairment in longitudinal, circumferential,
and radial deformation was found in a large number of
patients with a wide range of AS severity, suggesting a
progressive subendocardial to transmural impairment of
myocardial function with increasing LV afterload [30]. In
asymptomatic patients with severe AS all three compo-
nents of myocardial deformation were more impaired in
patients with higher global LV afterload and in patients
with a low stroke volume index [31]. The authors sug-
gested that a decrease in circumferential function in pa-
tients with AS may be a marker of an advanced stage of
the disease and could identify patients at higher risk,
particularly when it is associated with a low-flow state.
However, data regarding circumferential and radial LV
deformation are not consistent between studies [5,31], in
part because of a higher variability of these parameters.
On the other hand, GLS seems to be a more robust par-
ameter and emerged as a potentially useful tool in the as-
sessment of subclinical LV dysfunction in AS (Figure 2).
Echocardiographic parameters of longitudinal LV func-
tion (such as MAPSE and GLS) allow an indirect assess-
ment of fibrotic changes in patients with AS. They are
surrogate markers of the presence and severity of myocar-
dial fibrosis and are superior to LVEF in the assessment of
latent LV dysfunction. Although myocardial reflectivity is
directly related to myocardium collagen content and can
be quantitatively assessed using ultrasonic backscatter sig-
nal [32], this technique is not widely used in clinical
practice.
Left ventricular torsional deformation has an important
role in both LV ejection and filling [33,34]. An increased
apical rotation leading to an increased LV torsion wasFigure 2 Left ventricular global longitudinal strain (GLS) measured by speckle
AS, a similar degree of concentric LVH and LVEF > 60%. Reduced values of lon
patient, but with a GLS value within normal range (−20%) (A). Impaired GLS (−
of longitudinal deformation in the basal segments (B). Stress echocardiography
at a low level of exercise while the first remained asymptomatic. Angiography indemonstrated by 2D-STE in symptomatic patients with se-
vere AS and preserved LVEF [35,36], with a normalization
of these parameters 6 months after AVR [36]. Delayed LV
diastolic untwisting, significantly related to increased LV
filling pressures, was also reported in these patients [35].
The assessment of LV diastolic function in patients
with AS should be performed using the existing recom-
mendations [37] and taking into account the limitations
imposed by different associated conditions (e.g. mitral
annular calcification, significant mitral or aortic regurgita-
tion, atrial fibrillation). Reduced values of mitral annulus
early diastolic myocardial velocity (e') and higher values of
E/e' ratio were found in asymptomatic patients with mod-
erate AS when compared to controls indicating an early
impairment of diastolic function [38]. In patients with
moderate to severe AS, E/septal e' ratio was validated for
the estimation of LV filling pressures against cardiac
catheterization, a value ≥13 identifying an LV end-
diastolic pressure >15 mmHg with good accuracy [4].
Doppler transthoracic or transoesophageal echocardi-
ography, usually with intravenous adenosine infusion,
allow the noninvasive evaluation of coronary flow re-
serve, a surrogate for the coronary microcirculation in
patients with normal angiographic coronary arteries.
Most studies conducted in patients with significant AS
showed that coronary flow under resting conditions is
significantly higher and hyperemic flow velocity is lower
compared with controls [39].
The current recommendations for stress echocardiog-
raphy in patients with AS are still limited [2,3]. The assess-
ment of LV contractile reserve using low-dose dobutamine
stress test has clear prognostic implications in patients
with low flow low gradient AS and reduced LVEF [40].
The evaluation of LV function during exercise can also pro-
vide incremental prognostic information in asymptomatic
patients with severe AS. A decrease or a limited increase in
LVEF at exercise is associated with a markedly reduced
midterm cardiac event-free survival [41]. Moreover, thetracking echocardiography in two asymptomatic patients with severe
gitudinal deformation in the basal LV segments are observed in the first
15%) was found in the second patient, with more severely reduced values
was performed in both patients. The second patient experienced dyspnea
the second patient revealed no significant coronary lesions.
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tect latent LV systolic dysfunction compared to changes in
LVEF [42].
The evaluation of vascular afterload is a useful add-
itional diagnostic tool in patients with AS. It was dem-
onstrated that both carotid and aortic stiffness are
associated with increased LV filling pressures, plasma
BNP and symptoms in patients with moderate and se-
vere AS [43]. Moreover, increased aortic rigidity is inde-
pendently related to impaired longitudinal LV function
in patients with severe AS and preserved LVEF [44]. The
study of these parameters may identify patients at a more
advanced stage of the disease, although their independent
prognostic value awaits confirmation in larger prospective
studies. Conversely, no relationship was demonstrated be-
tween pulse wave velocity, the most widely used param-
eter of arterial stiffness, and LVEF, in patients with
significant AS undergoing AVR [45].
Valvulo-arterial impedance, which provides an esti-
mate of the global LV haemodynamic load, is superior to
the standard indexes of AS severity in predicting LV dys-
function. Its independent prognostic value was already
demonstrated in both symptomatic and asymptomatic
patients with significant AS [13,46].Cardiac magnetic resonance imaging
In patients with AS, CMR allows the quantification of
the severity of valve disease, provides additional infor-
mation regarding the enlargement of the ascending aorta
and the consequences of pressure overload on LV struc-
ture and function.
There has been growing interest in the assessment of
myocardial fibrosis by CMR. The development of diffuse
fibrosis emerged as a key mechanism for the progression
to HF of patients with AS [17] and a potential treatment
target [47]. By the use of equilibrium contrast CMR an
increased level of diffuse myocardial fibrosis was found
in patients with severe AS awaiting surgery [48], but
with a considerable overlap between patients and con-
trols. The degree of diffuse fibrosis was not correlated to
LV mass or LVEF, but it was the strongest determinant
of functional status at baseline.
Late gadolinium enhancement (LGE) CMR is the gold
standard imaging method for assessing focal, replace-
ment fibrosis [48] (Figure 3). In symptomatic patients
with severe AS myocardial replacement fibrosis is found
mainly in the subendocardial layer of the LV and its de-
gree decreases from the base to the apex [49,50]. Its
presence was associated to decreased LV longitudinal
function and poor postoperative outcome [49]. A peak
systolic longitudinal strain of less than −11.6% has a sen-
sitivity of 65% and a specificity of 75% for predicting
myocardial fibrosis (defined as LGE >10%) [50].Patients with paradoxical low-flow low gradient AS have
a higher degree of myocardial fibrosis and a more impaired
LV longitudinal function when compared to patients with
normal flow high gradient AS [23]. These changes may
contribute to their reduced LV stroke volume and trans-
valvular gradient and the worse outcomes [13,23,24].
The assessment of myocardial fibrosis by CMR may in
the future refine the selection of asymptomatic patients
with severe AS, who may benefit from early interven-
tion, although this requires confirmation in larger pro-
spective studies.
Subclinical deterioration of LV function can also be
assessed by CMR, which is considered the reference stand-
ard for the assessment of myocardial deformation [51]. A
few clinical studies using tagged CMR demonstrated for
the first time that LV torsion is increased, and LV untwist-
ing is delayed in patients with significant AS [52].
Given its complexity, high cost and limited availability,
the utility of CMR for the assessment of LV strain in AS
remains confined to research in certain academic centers.
Myocardial perfusion reserve may also be assessed by
CMR and is independently associated with objectively
measured exercise capacity in patients with severe AS [53].Computed tomography
Multi-slice cardiac computed tomography (CT) offers
additional data regarding the ascending aorta and the LV
outflow tract in patients with AS, and is useful in quan-
tifying the valvular and coronary calcification, with spe-
cific application in patients who are eligible for a
transcatheter AVR [2]. This technique may also be used
to exclude coronary artery disease (CAD) in younger pa-
tients with AS who are at low risk of atherosclerosis [2].
However, invasive coronary angiography is strongly rec-
ommended when CAD is a concern.
Although the assessment of LV volumes and global
function by cardiac CT has a wider availability when
compared to CMR, its utility in patients with AS is not
established in clinical practice.
Positron emission tomography allows the noninvasive
quantification of the transmural distribution of myocar-
dial blood flow. Myocardial flow reserve can also be
evaluated using dynamic perfusion imaging at rest and
during dipyridamole stress. This parameter is more se-
verely impaired in the subendocardial layers of the LV in
patients with LV hypertrophy atributable to severe AS and
angiographically normal coronary arteries. In patients with
low-flow, low-gradient AS a higher resting myocardial
blood flow and a reduced flow reserve (linked to the AS
severity) were also found using this technique [54].
The comparative role of currently used noninvasive
imaging techniques in the assessment of LV structure
and function in AS is illustrated in Table 1.
Figure 3 Late gadolinium enhancement (LGE) CMR in basal to apical short axis (A-C) and systolic frame Cine CMR through the aortic valve (D) in
a patient with severe AS. Patchy diffuse LGE may be observed (A-C) together with a severely reduced valve area (D). Courtesy of Dr Anca Florian,
Dept. of Cardiology, Uniklinikum Muenster, Germany.
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assessment of LV function
Varying degrees of mitral regurgitation (functional or or-
ganic) are often found in patients with severe AS. Con-
comitant severe mitral regurgitation may lead to an
overestimation of LVEF and LV fractional shortening.
Left ventricular remodelling is a determinant of func-
tional mitral regurgitation not only in patients with AS
and reduced LVEF but also in patients with preserved
LVEF. A significant inverse correlation was found be-
tween effective regurgitant orifice area and LV systolic
longitudinal shortening in these patients, suggesting that
subclinical LV dysfunction might compromise proper
mitral valve function [55].
Significant CAD is present in more than 50% of patients
with severe AS who are over 70 years [56]. A lower LVEF
and a more impaired longitudinal and radial LV function
were found in patients with AS in the presence of con-
comitant CAD [57] (Figure 4). These patients have a
worse prognosis, more post-operative morbidity and in-
creased mortality related to the effects of pre-existing is-
chemic myocardial damage and comorbidities [58].
Prognostic significance of left ventricular remodelling in
aortic stenosis
Current guidelines strongly recommend AVR in all pa-
tients with severe AS when associated with either symptomrelated to AS or an abnormal LVEF (<50%) [2]. In clinical
practice, most asymptomatic patients with severe AS have
a preserved LVEF and require a careful risk stratification in
order to choose between early elective intervention and
watchful waiting. Efforts are being made to anticipate the
onset of symptoms in patients with severe AS and identify
early signs of myocardial dysfunction.
In symptomatic patients with severe AS, AVR is firmly
indicated but further risk stratification may be needed in
patients with severely impaired LV function or extensive
comorbidities, especially with the recent extent of trans-
catheter AVR interventions.
The prognostic value of LV dysfunction in patients
with AS was demonstrated by Lund et al. [59] in symp-
tomatic patients with AS undergoing AVR. Left ventricu-
lar ejection fraction <60% and diastolic dysfunction
assessed by radionuclide ventriculography were the only
independent risk factors for early death.These results
were further confirmed by more recent data, LVEF being
identified as an independent predictor of all-cause mor-
tality in patients with significant AS, irrespective of the
presence of symptoms [60].
Beyond LVEF, excessive LVH and abnormal TDI param-
eters of LV function are cited by the current guidelines [2]
as predictors of symptom development and adverse out-
comes in asymptomatic patients with AS, although spe-
cific cut-off values are not provided. Inappropriately high




(LV mass and RWT)
- mandatory for classification of LV remodelling - less accurate and reproducible estimation of LV mass
compared to CMR, in particular in patients with large
left ventricles- easy to perform
- demonstrated prognostic value
LV ejection fraction - established prognostic value in patients with AS - overestimates LV systolic function in this setting
- practical implications in the decision making process - difficult to measure in patients with suboptimal
acoustic window
MAPSE - widely available and easy to measure - problematic in patients with mitral annular calcification
- useful for the detection of LV longitudinal dysfunction
Peak systolic myocardial
velocity (by TDI)
- early marker of LV dysfunction especially when assessed during
or after exercise in patients with asymptomatic AS
- angle dependent




- relatively easy to obtain parameter quantifying longitudinal LV
systolic function
- requires good image quality and dedicated software




- allow noninvasive estimation of LV filling pressures - less accurate in patients with associated mitral annular
calcification and/or significant mitral regurgitation




- gold standard assessment of LV volumes, mass and EF as well as
myocardial deformation
- high cost and limited availability
- allows the detection and quantification of interstitial and focal
myocardial fibrosis - demonstrated prognostic value in AS
- adverse reactions after i.v. administration of
gadolinium-based contrast agents
- results from LGE method vary between different
imaging studies (less suitable for folow up studies)
- the equilibrium contrast method for the assessment
of diffuse fibrosis is still complex and time-consuming
Computed
tomography
- allows the assessment of LV volumes and global LV function - exposure to radiation and potential contrast nephrotoxicity
- wider availability when compared to CMR - limited data regarding LV function assessment in AS
patients
Figure 4 Left ventricular longitudinal strain measured by speckle tracking echocardiography in a patient with severe aortic stenosis and chest
pain. A nonuniform reduction of longitudinal deformation can be observed, with reduced values of peak systolic strain in the basal segments of
the interventricular septum (yellow arrows) and post-systolic shortening in mid and basal segments of the lateral wall (white arrows). Coronary
angiography revealed a calcified left main stenosis (80%) extended to the origin of the circumflex artery and a hypoplastic right coronary artery.
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verse events in asymptomatic patients with severe AS
[61]. On the other hand, in symptomatic patients, in-
creased RWT but not LV mass was associated with in-
creased risk of in-hospital mortality after AVR [62]. Only
patients with a normal LV mass index and RWT had a
survival benefit when compared to those with any pattern
of abnormal LV geometry [63].
Most of the available data suggest that TDI and STE
derived indices of LV function might be useful for risk
stratification in both symptomatic and asymptomatic pa-
tients with AS although they need validation in larger
studies. A summary of the most important clinical stud-
ies addressing this issue is presented in Table 2.
Both E/e' ratio (as an expression of LV filling pres-
sures) and GLS (as a marker of LV subendocardial func-
tion) can be easily measured in most patients with AS
and have the potential of becoming useful tools for risk
assessment in clinical practice. However, their incremen-
tal prognostic value over well-known haemodynamic pa-
rameters of AS severity was not clearly demonstrated.
After accounting for the severity of AS, neither indexed
LV mass nor any TDI derived parameter of LV function
provided additional predictive information in asymptom-
atic patients [71]. On the other hand, low values of GLS
were independently associated to increased all-cause
mortality when adjusting for several established risk fac-
tors (including symptoms, LVEF and haemodynamic se-
verity) [66,68].
Echocardiographic parameters of LV longitudinal func-
tion are strongly linked to the extent of myocardial fi-
brosis, which has clear prognostic implications [49].
Midwall myocardial fibrosis was associated with an 8-
fold increase in all-cause mortality in patients with sig-
nificant AS[60] while focal fibrosis was an independent
predictor of increased perioperative risk and mortality in
patients with AS undergoing surgical AVR [72].
Therefore, the echocardiographic assessment of LV
longitudinal deformation allows estimation of LV suben-
docardial fibrotic changes and may become a tool for
risk stratification in patients with significant AS. So far,
the clinical utility of GLS is hindered by the lack of
standardization on different echo machines and lack of
specific cut-off values.
B-type natriuretic peptide (BNP) is a useful tool in risk
stratification of asymptomatic patients with AS, although
absolute threshold values were not adequately validated
for use in clinical practice. An increase in serial BNP
levels may identify a subgroup of patients with a higher
degree of diastolic LV dysfunction and latent LV systolic
dysfunction that may precede symptom development
[73]. A serum BNP level higher than the normal upper
limit for each individual patient (defined as BNP clinical
activation) was a powerful predictor of long-termmortality, incrementally and independently of all base-
line characteristics in a large cohort of patients with
moderate and severe AS [74].
In a retrospective study in a large cohort of high risk
patients who underwent transcatheter AVR low flow (LV
stroke volume index < 35 ml/m2) was an independent
predictor of cumulative all-cause and cardiovascular
mortality [75]. A post-hoc analysis from the PARTNER
(Placement of Aortic Transcatheter Valves) trial showed
that low flow was an independent predictor of mortality
in both the inoperable and high risk cohorts, whereas
LV EF and transvalvular gradient were not [76]. More-
over, in patients with low-gradient severe AS and pre-
served EF, indexed LV stroke volume emerged as the
most powerful echocardiographic parameter associated
with long-term outcome, with a 20% increase in adjusted
mortality risk for each 5 ml/m2 reduction in stroke vol-
ume index [77]. More recent data confirm that lower
values of indexed LV stroke volume are independently
and incrementally associated with increased mortality in
these patients [78].
Dobutamine stress echocardiography provides import-
ant prognostic information in patients with low-flow low
gradient AS by assessing LV contractile reserve, which
aids therapeutic decision-making [40]. Incorporating
measurement of peak stress longitudinal strain parame-
ters may add incremental prognostic value [79].Conclusions and future perspectives
The consequences of increased afterload on the LV
should always be taken into account for a comprehen-
sive assessment of patients with AS. Beyond the conven-
tional assessment of LV mass and ejection fraction, the
assessment of LV deformation parameters (in particular
STE derived GLS) and myocardial fibrosis (estimated by
CMR) will probably be increasingly used in the decision
making process in patients with AS in the near future.
Although proper standardization and confirmatory data
from large prospective studies are needed before incorp-
orating such new parameters into practical management
algorithms, their close monitoring may prevent irrevers-
ible myocardial damage and the risk related to delayed
symptom reporting. Exercise echocardiography may pro-
vide incremental prognostic value by assessing both
exercise-induced symptoms and changes in valve
haemodynamics, LV function, and pulmonary pressures.
Such an inclusive approach can aid in timing the inter-
vention in apparently asymptomatic patients with severe
AS and stratify risk in patients undergoing AVR.
In view of the fact that no single parameter of LV
function predicts the optimal timing for AVR in asymp-
tomatic patients, all available information must be con-
sidered for optimal decision-making in clinical practice.
Table 2 Independent predictors of adverse events in patients with aortic stenosis - results of studies assessing modern echocardiographic parameters
Independent predictors Cut-off
values
Population Adverse events Follow-up Reference
- Basal longitudinal strain (STE) −13% - 65 asymptomatic pts with AS,
AVA < 1 cm2, LVEF >55%
Combined end-point: re-hospitalization for
any cardiac cause, aortic valve surgery,
cardiovascular death within 12 months
12 months Lafitte et al. [5]
- Systolic annular velocity (TDI) - 126 asymptomatic pts with
AVA≤ 1,2 cm2, LVEF >55%
Combined end point: onset of symptoms;
cardiac-related death; need for AVR
20.3 ± 17.8 months
(median follow-up
period)
Lancellotti et al. [64]
- Late diastolic annular velocity
(TDI)
- E/e' ratio
- Indexed LA area
- BNP
- LV longitudinal deformation (STE) - 15.9% - 163 asymptomatic pts with
AVAi < 0.06 cm2/m2; LVEF >55%
Combined end-point: cardiac death;
development of significant symptoms;
clinical need of AVR
20 ± 19 months Lancellotti et al. [65]
- Peak aortic jet velocity 4.4 m/s




- Indexed LA area
- Global LV longitudinal strain (STE) −15% - 79 asymptomatic patients with
severe AS (AVA <1 cm2 or transaortic
jet velocity >4 m/s) and LVEF≥ 50%
Combined end-point: cardiac death;
AVR driven by symptom development
23 ± 20 months Yingchoncharoen
et al. [66]
- STS-PRMM
- Aortic valve calcification score
- AVA
- Valvuloarterial impedance
- E/e’ ratio (lateral annular site) 15 - 125 symptomatic and asymptomatic
unoperated patients with severe AS
All cause death 1 year Biner et al. [67]
- BNP 300 ng/ml
- Global LV longitudinal strain (STE) −15%
(−12.8%*)
- 146 symptomatic and asymptomatic
pts with mild, moderate and severe AS
All-cause mortality median follow-up of
2.1 years















Table 2 Independent predictors of adverse events in patients with aortic stenosis - results of studies assessing modern echocardiographic parameters
(Continued)
- Systolic peak radial strain
rate (TDI)
2/s - 32 symptomatic patients with AVR for
severe AS (AVA < 1 cm2, LVEF 61 ± 10% )
Combined end-point: cardiovascular death,
worsening of HF and limited exercise capacity
12 months Bauer et al. [69]
- e'
- E/Vp
- Global LV longitudinal
strain (STE)**
- 125 symptomatic pts with severe
AS and LVEF >40% undergoing AVR
Combined end point: cardiovascular mortality and
cardiac hospitalization due to worsening of HF
mean follow-up of 3.8 ±
1.5 years
Dahl et al.[70]
TDI, Tissue Doppler imaging; STE, speckle tracking echocardiography; AVA, aortic valve area; AVAi, indexed aortic valve area; LVEF, left ventricular ejection fraction; LA, left atrium; STS-PRMM, Society of Thoracic
Surgeons Predicted Risk of Morbidity and Mortality; E, early diastolic transmitral velocity; e’, mitral annulus early diastolic velocity, Vp, velocity of flow propagation into the left ventricle.
*, this threshold provided the best combination of sensitivity (83%) and specificity (87%) for all-cause mortality.
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